D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Helix Energy Solutions
HLX
$1.42B
| $462K | ﹤0.01% |
49,588
-26,021
| -34% | -$262K |
|
|
SII
3527
Sprott
SII
$2.7B
| $459K | ﹤0.01% |
10,900
+2,800
| +35% | +$123K |
|
3528
DMC Global
BOOM
$117M
| $457K | ﹤0.01% |
62,146
-69,167
| -53% | -$653K |
|
3529
ArcelorMittal
MT
$50.9B
| $456K | ﹤0.01% |
19,722
-46,858
| -70% | -$1.16M |
|
3530
Blue Owl Capital
OWL
$6.54B
| $456K | ﹤0.01% |
+19,600
| New | +$449K |
|
|
GEAR
3531
CALL
DELISTED
Revelyst, Inc.
GEAR
| $456K | ﹤0.01% |
+23,700
| New | +$452K |
|
|
GEAR
3532
DELISTED
Revelyst, Inc.
GEAR
| $455K | ﹤0.01% |
+23,640
| New | +$451K |
|
|
NOAH
3533
Noah Holdings
NOAH
$595M
| $454K | ﹤0.01% |
+38,760
| New | +$480K |
|
3534
Biomea Fusion
BMEA
$91.1M
| $453K | ﹤0.01% |
+116,653
| New | +$930K |
|
3535
MaxCyte
MXCT
$109M
| $452K | ﹤0.01% |
108,601
+84,105
| +343% | +$318K |
|
3536
Transmedics
TMDX
$2.57B
| $452K | ﹤0.01% |
+7,242
| New | +$674K |
|
3537
Dimensional International Value ETF
DFIV
$20.9B
| $451K | ﹤0.01% |
+12,725
| New | +$467K |
|
3538
Gold Royalty Corp
GROY
$609M
| $451K | ﹤0.01% |
373,094
-29,992
| -7% | -$40K |
|
3539
Lifestance Health
LFST
$4.15B
| $451K | ﹤0.01% |
+61,247
| New | +$440K |
|
3540
Aquestive Therapeutics
AQST
$468M
| $450K | ﹤0.01% |
126,464
+95,418
| +307% | +$440K |
|
3541
PUT
Guardant Health
GH
$19.3B
| $449K | ﹤0.01% |
14,700
-2,200
| -13% | -$61.9K |
|
3542
PUT
Kadant
KAI
$3.69B
| $448K | ﹤0.01% |
1,300
-300
| -19% | -$109K |
|
3543
Elbit Systems
ESLT
$38.1B
| $448K | ﹤0.01% |
1,736
-391
| -18% | -$91.7K |
|
|
PSTL
3544
Postal Realty Trust
PSTL
$722M
| $448K | ﹤0.01% |
+34,319
| New | +$481K |
|
3545
KB Home
KBH
$3.53B
| $446K | ﹤0.01% |
6,787
-8,903
| -57% | -$693K |
|
3546
OceanFirst Financial
OCFC
$1.7B
| $446K | ﹤0.01% |
24,636
-87,709
| -78% | -$1.67M |
|
3547
PUT
InterDigital
IDCC
$6.7B
| $446K | ﹤0.01% |
+2,300
| New | +$402K |
|
3548
CALL
Weibo
WB
$1.92B
| $445K | ﹤0.01% |
46,600
-2,300
| -5% | -$22K |
|
3549
Apogee Therapeutics
APGE
$10.2B
| $445K | ﹤0.01% |
9,813
-39,849
| -80% | -$2.03M |
|
3550
CALL
Biogen
BIIB
$29.5B
| $443K | ﹤0.01% |
2,900
+500
| +21% | +$84.3K |
|
Similar funds
D.E. Shaw & Co's Q4 2024 Portfolio in Review
As of Q4 2024, D.E. Shaw & Co held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- D.E. Shaw & Co's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- D.E. Shaw & Co's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- D.E. Shaw & Co fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- D.E. Shaw & Co opened 591 new positions and closed 731 in Q4 2024.
- D.E. Shaw & Co's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.